Imagion Biosystems Limited is pleased to provide investors with its May 2020 Investor Newsletter.
The newsletter details recent key company developments and activities including:
- Message from the CEO, Mr Robert Proulx
- Switzer interview
- Receipt of $2.2m R&D tax incentive
- Q&A with Ms Dianne Angus, recently appointed Non-Executive Director
- Imagion’s new website
- IBX in the news
Read the newsletter.